Research
Nanotronics Announces Opening of Munich Office
Investment in European Expansion to Support New Hires and Business Growth in Key Region 14/11/2022 — NEW YORK — (BUSINESS WIRE) Nanotronics is pleased to announce the opening of an […]
Seagen Names David R. Epstein as Chief Executive Officer and Director
-Roger Dansey, M.D., Appointed President, Research and Development – 10/11/2022 — BOTHELL, Wash. — (BUSINESS WIRE) Seagen Inc. (Nasdaq: SGEN) today announced that its Board of Directors has appointed David […]
Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
Collaboration Includes Industry-Leading Technologies and Decentralized Clinical Trial Capabilities to Increase Study Efficiency and Patient Engagement 27/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, and Boehringer […]
TenCate Protective Fabrics and Saxion University of Applied Sciences Sign MoU
20/10/2022 — NIJVERDAL, Netherlands — (BUSINESS WIRE) On September 15th, a large delegation from TenCate Protective Fabrics paid a visit to Saxion University’s Sustainable & Functional Textiles research group (Enschede, […]
New Medidata Technology Helps Sponsors and CROs Improve Diversity and Inclusion in Clinical Trials
Intelligent Trials Diversity Module Addresses Critical Need to Increase Study Access and Engagement 13/10/2022 — NEW YORK — (BUSINESS WIRE) Medidata, a Dassault Systèmes company, has launched the Intelligent Trials […]
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
15/09/2022 — BRISTOL, N.J. & SEOUL — (BUSINESS WIRE) Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that […]
Thermo Fisher Scientific Launches CE-IVD Marked TaqPath Respiratory Viral Select Panel
The PCR assay panel tests for five respiratory viruses in under three hours 11/07/2022 — CARLSBAD, Calif. — (BUSINESS WIRE) Thermo Fisher Scientific, the world leader in serving science, today […]
Mary Kay Inc. Partners With Dr. Jack Gilbert to Further Study Skin’s “Microbiome” and the Impact on the Aging Process
07/07/2022 — DALLAS — (BUSINESS WIRE) Mary Kay Inc., one of the world’s leading skincare research companies, has announced a new partnership with Dr. Jack Gilbert, professor of pediatrics at […]
NICE Publishes Final Appraisal Document Recommending the Use of Adtralza® (tralokinumab) for Adult Patients With Moderate-to-Severe Atopic Dermatitis
NICE Publishes Final Appraisal Document Recommending the Use of Adtralza® (tralokinumab) for Adult Patients With Moderate-to-Severe Atopic Dermatitis The National Institute for Health and Care Excellence (NICE) has published a […]
Mary Kay Inc. Presents New Findings on Pollution and Skin Health at Society for Investigative Dermatology Conference
23/06/2022 — DALLAS — (BUSINESS WIRE) Mary Kay Inc., a global leader in skin care innovation, continued its ongoing support of the beauty and scientific communities recently by sponsoring the […]
Boly Media says its CTO has found hidden but fatal errors In Special Relativity
09/06/2022 — SANTA CLARA, Calif. — (BUSINESS WIRE) In the process of finding the best technologies for solving the Renewable Energy issue, the CTO of Boly Media Holdings Co., Dr. […]
Agendia Presents Data from the FLEX Real World Evidence Trial in Seven Posters at ASCO 2022, Showcasing the Power of Its 30,000-Patient Breast Cancer Genome Project
Data show MammaPrint® is the first and most comprehensive FDA-cleared test for early breast cancer resulting in the ability to identify women who may be over- or under-treated if treatment […]
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
27/05/2022 — GUANGZHOU, China — (BUSINESS WIRE) LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary […]
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
Emendo Biotherapeutics revealed pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, generating a highly specific editing composition that achieves both no off-targets and […]
Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program
Lead AMHR2 agonist compound demonstrates high specific activity in biological assays and desired pharmacokinetic profile in preclinical animal studies 16/05/2022 — NEW YORK — (BUSINESS WIRE) Celmatix Inc. a biotechnology […]
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Study results were included in the submission to Health Canada leading to Notice of Compliance 05/05/2022 — QUEBEC CITY — (BUSINESS WIRE) Medicago today announced the publication of the results […]
Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Support U.S. Public Health Initiatives
INNOVATIVE RESPONSE SUPPORTS FUTURE RESPONSES AGAINST SIMILAR PANDEMIC THREATS First results from the CDC SARS-CoV-2 U.S. variant surveillance program to be published Positive COVID samples sequenced for variant surveillance in […]
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
26/04/2022 — MENLO PARK, Calif. & COPENHAGEN, Denmark — (BUSINESS WIRE) Evaxion Biotech A/S (Nasdaq: EVAX) and Personalis (Nasdaq: PSNL) announced today that Evaxion will deploy Personalis’ ImmunoID NeXT Platform […]
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
Tool detects increasingly important biomarker for immunotherapy 12/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the […]
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
Profiling feasibility study uses a combined transcriptome and exome approach to confirm and augment upon previous molecular subtyping method in colorectal cancer 11/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) […]
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
23/03/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting new data in scientific posters at […]
Agendia Appoints Elizabeth Hanna as Executive Vice President and Chief Commercial Officer, Bolsters Company’s Global Market Growth Strategy
15/03/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that […]
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
A vaccine manufactured in plants and developed in Canada 24/02/2022 — QUEBEC CITY & LONDON — (BUSINESS WIRE) Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today […]
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
15/02/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a strategic collaboration with the Moores Cancer Center […]
Agendia Study Demonstrates MammaPrint® and BluePrint® Capture Full Spectrum of Early Breast Cancer Biology, Providing Opportunity for Highly Individualized Treatment
New analysis in peer-reviewed journal Genes, Chromosomes and Cancer further establishes that MammaPrint and BluePrint both comprehensively represent and capture the 10 hallmarks of cancer in early-stage breast cancer Study […]
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing, to bring improved insights to patients with breast cancer globally 10/01/2022 — IRVINE, Calif. & AMSTERDAM — […]
Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate
Final portion of data submitted as part of New Drug Submission for COVID rolling review COVID-19 vaccine candidate fully developed in Canada submitted for authorization 16/12/2021 — QUEBEC CITY — […]
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
16/12/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of NeXT Personal, a next-generation, tumor-informed liquid […]
Agendia Spotlight Poster at SABCS 2021 Confirms Utility of BluePrint® as Biomarker Subtyping Test to Guide Neoadjuvant Chemotherapy Decisions
Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer 10/12/2021 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, […]
Medicago and GSK Announce Positive Phase 3 Efficacy and Safety Results for Adjuvanted Plant-Based COVID-19 Vaccine Candidate
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3% efficacy […]